Cargando…
Ethical and regulatory issues of stem cell-derived 3-dimensional organoid and tissue therapy for personalised regenerative medicine
BACKGROUND: Regenerative medicine has the potential to treat genetic disorders and replace damaged or missing tissue. The use of donor or animal tissue raises many well-known issues, including limited tissue availability, the possibility of rejection and patient infection. Stem cell therapy raised h...
Autores principales: | Harris, Alexander R., Walker, Mary Jean, Gilbert, Frederic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795739/ https://www.ncbi.nlm.nih.gov/pubmed/36575403 http://dx.doi.org/10.1186/s12916-022-02710-9 |
Ejemplares similares
-
Perceptions of ‘Precision’ and ‘Personalised’ Medicine in Singapore and Associated Ethical Issues
por: Ong, Serene, et al.
Publicado: (2021) -
Cell therapies for Duchenne muscular dystrophy: some ethical issues for personalised medicines
por: McCormack, Pauline
Publicado: (2010) -
Advancement of Organoid Technology in Regenerative Medicine
por: Arjmand, Babak, et al.
Publicado: (2022) -
Overcoming kidney organoid challenges for regenerative medicine
por: Geuens, Thomas, et al.
Publicado: (2020) -
Pancreatic Organoids for Regenerative Medicine and Cancer Research
por: Casamitjana, Joan, et al.
Publicado: (2022)